Bay Harbor Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Bay Harbor Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $4,866 - $5,523	-75 Closed	0 $0
Q3 2021 Nov 24, 2021	SELL	$67.69 - $73.03 $22,676 - $24,465	-335 Reduced 81.71%	75 $5,000
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $39,732 - $43,413	-626 Reduced 60.42%	410 $28,000
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $43,740 - $49,907	-729 Reduced 41.3%	1,036 $67,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $48,152 - $54,867	-850 Reduced 32.5%	1,765 $103,000
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $74,706 - $93,930	1,203 Added 85.2%	2,615 $165,000
Q2 2020 Jul 16, 2020	SELL	$72.34 - $84.0 $226,858 - $263,424	-3,136 Reduced 68.95%	1,412 $109,000
Q1 2020 May 20, 2020	BUY	$62.63 - $80.22 $16,221 - $20,776	259 Added 6.04%	4,548 $340,000
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $369 - $406	6 Added 0.14%	4,289 $279,000
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $262,479 - $289,731	4,199 Added 4998.81%	4,283 $269,000
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $5,085 - $6,636	84 New	84 $5,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.